Dental Tribune United Kindom Edition

G laxoSmithKline, mak- ers of Aquafresh, have teamed up with upcy- cling company TerraCycle UK to launch the Aquafresh oral care Brigade, a recycling fundraiser which encourages schools to col- lect used toothbrushes and tooth- paste tubes to be recycled and upcycled into everyday products. For every product brought in for recycling, 2p will be donated to a charity of the school’s choice. The scheme teaches children about resource conservation, whilst reinforcing good dental hygiene through educational ma- terials on brushing for kids. The Aquafresh oral care Bri- gade is open to primary schools, and youth groups such as scout and guiding across the UK who can get involved by signing up at www.terracycle.co.uk. A ma- jor PR campaign – focusing on nationals, educational titles, women’s interest and parenting titles will drive awareness of the scheme and encourage participa- tion. Rachel Deans, Group Brand Director for Aquafresh, said: “The scheme provides a perfect fit for the family friendly Aquafresh brand – which markets both adult and children’s products – engag- ing primary school students (and their parents!) in a hands on way to get involved in protecting our planet by recycling and reusing. By encouraging good eco-habits at a young age, we can instil a life- long drive to be more sustainable and responsible and by using fa- miliar packaging like toothpaste tubes and toothbrushes, children can more easily understand the results of their actions. “We are delighted to be able to work with TerraCycle as part- ner in this environmental fund- raising campaign. We hope that schools and groups will engage with the scheme to really make a difference to their local environ- ment and raise money for their local communities as well as helping to educate in children’s oral health. ” Chris Baker, General Manag- er of TerraCycle UK commented: “TerraCycle is fully committed to engaging children in learn- ing how to protect their environ- ment and help their local com- munities in this time of austerity. With the support of a familiar brand like Aquafresh, we are confident that we can reach thousands of schools and make a difference both locally and glo- bally!” For more information about the TerraCycle scheme, got to www.terracycle.co.uk. DT Aquafresh goes green! A n Edinburgh cosmetic dentist is to provide expert cosmetic and beauty advice on the second se- ries of lifestyle show MyFaceMy- Body. Dr Biju Krishnan, co-found- er of Lubiju’s cosmetic dental clinic, will appear on the SkyTV show, offering advice to adults searching for the perfect smile, as well as providing expert opin- ion on some of the latest cos- metic dentistry treatments on the market. The series launched with a special episode filmed at the Lubiju clinic, showcasing the treatments available at the clin- ic. One of these practices is NTI Splint treatment, which helps relieve the pain and discomfort caused by migraines, by com- bining a series of physiotherapy sessions with the traditional splint treatment to provide opti- mum results. Dr Krishnan said: “At Lu- biju we have some fantastic cosmetic dentistry treatments and the NTI splints are a per- fect example of how we as a clinic are leading the way in cre- ating new and innovative treat- ments. “The treatment combination, which uses NTI splints to stop the teeth from grinding as well as physiotherapy to help open up and strengthen the facial muscles, is the first of its kind in the UK and we are delighted to have been given the opportunity to showcase it on MyFaceMy- Body. “The show is a great platform for UK clinics outside of the UK to show how they are helping shape the future of cos- metic dentistry and make the phobic stigma attached to den- tistry a thing of the past.’’ DT Edinburgh Dentist A My Face My Body Expert 7NewsJuly 18-24, 2011United Kingdom EditionUnited Kingdom Edition N ICE has published a draft guideline on the initial assessment and referral following emergency treatment for a suspected ana- phylactic episode or a severe al- lergic reaction. An anaphylactic episode is an allergic response that is a severe, generalised or sys- temic hypersensitivity reaction that can lead to potentially life- threatening airway, breathing and/or circulation problems. Foods, such as peanuts, nuts, eggs, shellfish, milk, fish, and some seeds such as sesame, are a particularly common cause of anaphylactic reaction, especial- ly in children. Non-food causes include wasp or bee stings, natural latex (rubber), penicil- lin or any other drug or injec- tion. Medicinal products are much more common triggers of anaphylactic reaction in older people. A significant proportion of anaphylaxis is classified as idiopathic, in which there are significant clinical effects but no known cause. Because of inconsistencies in reporting anaphylaxis, and be- cause it is often misdiagnosed, there is no overall figure for the frequency of anaphylaxis from all causes in the UK. However, available UK estimates suggest that approximately 1 in 1,333 of the population of England has experienced anaphylaxis at some point in their lives. What is clear is that there has been a dramatic rise in the rate of hos- pital admissions for anaphylax- is. Between 1990 and 2004 they increased from 0.5 admissions per 100,000 to 3.6 per 100,000 - an increase of 700 per cent - resulting in approximately 20 deaths each year in the UK (al- though this may be a substan- tial underestimate). In addition, there is considerable geograph- ic variation in both practice and service provision, specifically in assessment after the event to confirm an anaphylactic epi- sode or on the decision to refer after emergency treatment. Draft recommendations in- clude: • Record the circumstances im- mediately before the onset of the reaction to help to identify the possible trigger. • All children given emergency treatment for a first suspected anaphylactic episode should be admitted to hospital under the care of a paediatric specialist team. • Following emergency treat- ment, all patients who have been referred following a sus- pected anaphylactic episode (and, if appropriate their carer and/or family) should be given an adrenaline injector as an in- terim measure pending the re- ferral appointment. • Each primary care organisa- tion and hospital should have a referral pathway for patients who have received emergency treatment for a suspected ana- phylactic episode. Dr Fergus Macbeth, Director of the Centre for Clinical Prac- tice at NICE said: “Anaphylaxis is a very serious, potentially life-threatening reaction. Unfor- tunately, there is often a lack of understanding of the condition on the part of healthcare pro- fessionals both when making a diagnosis and of when or where to refer patients who have had a suspected anaphylaxis. This can affect the likelihood of the per- son receiving a definitive diag- nosis, which can lead to anxiety, inappropriate management and recurrent episodes. It can also give rise to avoidable costs for the NHS and increase the need for acute care. This guideline, the first of its type from NICE, will help healthcare profession- als who care for those who ex- perience this extreme response. I would recommend all those who are registered as stakehold- ers in the development of this guideline to submit their com- ments via the NICE website.” DT More information can be found at www.nice. o r g . u k / g u i d a n c e / i n d e x . jsp?action=folder&o=55280 Anaphylactic guidelines published